Torben Friis

Torben Friis

Managing Director and Global Head of Distribution at Match Liquidity DMCC

Torben handles relationships with LPs, Counterparties, and Vendors at Match Liquidity, a proprietary trading firm active in a range of asset classes.

Media
NewsSpotlightKnowledge hubExpertsAbout The SumsuberSumsub
Browse by content type
VideosPodcastGuides & ReportsWebinarsSpecial projects
Browse by industry
FintechCryptoiGaming
Browse by region
AfricaAsiaEuropeNorth AmericaOceaniaSouth America

Sum&Substance is registered with the Information Commissioner’s Office in line with the Data Protection Act 2018. Supports 256-bit TLS encryption on every device

Icon UKAS
Icon IDVT
Icon SOC
Icon GRC
Icon PCI
Icon GDPR
Icon ISO 31000
Icon ISO 9001
Icon Google PlayIcon Google Play
Sumsub logo

© Sumsub, 2015-2026. All rights reserved.

Data Protection Registration Number: ZA222205. Company Registration Number: 09688671. Address: 30 St. Mary Axe, London, England, EC3A 8BF

The information contained in The Sumsuber is provided for informational purposes only. Nothing on this website constitutes, or should be relied upon as, legal advice. Any opinions expressed by contributors featured in The Sumsuber are solely their own and do not necessarily reflect the views of Sumsub.

No representations or warranties of any kind, express or implied, are made with respect to The Sumsuber, its content, materials, information, or any services or links provided through it, including without limitation any warranties of accuracy and completeness of any information.

The material on this website may not reflect the most recent developments. Laws and regulations vary by jurisdiction and are subject to change. Readers should not act on any information contained in The Sumsuber without seeking professional advice. All liability, whether direct, indirect, consequential, or otherwise, for any loss, damage, or inconvenience arising from the use of, or reliance on, any information contained on this website or any linked resources is hereby disclaimed.